Financials
- Market Capitalization 162.59 M
- Employee 118
- Founded 2010
- CEO N/A
- Website www.cibus.com
- Headquarter Delaware, United States
- FIGI BBG00H1CJS11
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.63
Relación precio/flujo de caja
21.88
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3750 | LENZ LENZ Therapeutics, Inc. - Common Stock | 5.23 USD | -6.44% | -6.77% | -24.20% | -83.91% | 163.98 M USD | ||
| 3751 | ANTX AN2 Therapeutics, Inc. - Common Stock | 4.55 USD | +1.11% | +2.94% | -4.01% | +321.30% | 163.87 M USD | ||
| 3757 | ORMP Oramed Pharmaceuticals Inc. - Common Stock | 3.96 USD | -1.98% | -13.73% | +2.06% | +86.79% | 162.07 M USD | ||
| 3758 | MOLN Molecular Partners AG - American Depositary Shares | 4.01 USD | 0.00% | +0.25% | +4.16% | +10.77% | 161.90 M USD |